The specter of an "embargo" on the supply of medicines seems to hang over Greece. After the Danish Novo Nordisk, also the compatriot Leo Pharma withdraws its products from the Greek market, as a form of protest against the decision of the Athens government to cut the price of 25% drugs, as reported by the BBC News. In particular, Leo Pharma has decided to suspend the sales of two very popular medicines, an anti-platelet agent and a treatment for psoriasis, because their price reduction could cause job losses. And according to Kristian Hart Hansen, director of the company, the cut of the 25% made to deal with the crisis the country is dealing with could encourage similar measures in other states with public debt problems, such as Ireland and Italy itself. In recent days, Novo Nordisk also withdrew an anti-diabetic drug from the market in Greece, for the same reasons. But the Hellenic country is not there. According to Stefanos Combinos, director general of the Greek economy ministry, pharmaceutical companies have already made "gold deals" in recent decades and are obliged to accept the reduction in prices. Pharmacist33 – 2 June 2010 – Year 6, Number 101
